Therapeutic use of the substituted pyrimidine, KP544, as a potential pharmacotherapy for the 3-nitropropionic-acid-induced behavioral deficits in a mouse model of Huntington's disease

R A Myers, Gary Dunbar

Research output: Other contribution

Original languageEnglish
StatePublished - May 20 2005

Fingerprint

Dive into the research topics of 'Therapeutic use of the substituted pyrimidine, KP544, as a potential pharmacotherapy for the 3-nitropropionic-acid-induced behavioral deficits in a mouse model of Huntington's disease'. Together they form a unique fingerprint.

Cite this